Bharat Biotech announces termination of its MOU with Precisa Medicamentos & Envixia Pharmaceuticals to sell COVAXIN in Brazil. We'll continue to work diligently with ANVISA, the Brazilian drug regulator to complete the regulatory approval process for the vaccine: Bharat Biotech pic.twitter.com/gi20i8rbRA— ANI (@ANI) July 23, 2021
(SocialLY brings you all the latest breaking news, fact checks and information from social media world, including Twitter (X), Instagram and Youtube. The above post contains publicly available embedded media, directly from the user's social media account and the views appearing in the social media post do not reflect the opinions of LatestLY.)













Quickly


